medigraphic.com

2002, Number 4

<< Back Next >>

Cir Cir 2002; 70 (4)

Sugiura operation, abdominal time, and sclerotherapy in patients with hemorrhagic portal hypertension, a 10-year experience

Martínez-Carabarin D, Vecerra-Hernández CP, Huerta-Jiménez M, Rueda-Torre G, López-Moltalvo S, Leticia-Díaz C

Language: Spanish
References: 20
Page: 226-231
PDF size: 82.18 Kb.


ABSTRACT

Objective: Sugiura modified procedure and sclerotheraphy. Type of study: Descriptive, bi-analytical, observing, lengthwise. Material and methods: A total of 122 patients were operated on following a scheduled for hemorrhagic portal hypertension (HPH), for which Sugiura modified procedure was applied, plus sclerotherapy for a period of 10 years, with a follow-up of 3 years. Results: A total of 122 patients with HPH were operated on, 39 (31.9%) female and 83 (68.1%) male, with a range between 20 and 65 years of age (average 43.3 years). These patients were classified as child-A 55 (45.1%) and child-B 57 (54.9%). Etiology of HPH was syndrome of Budd-Chiari in one (1.2%), thrombosis of porta in three (2.4%), viral hepatitis in 28 (22.9%), and hepatic cirrhosis nutritional alcoholic (CHAN) in 90 (90.7%). Patients were hospitalized for 3-10 days (average 6.5 days), mortality in immediate postoperatory period of 2.4%. Endoscopic sclerotherapy of esophagic varicose veins with eradication was performed in 114 (93.44%), during the third session. During 3-year follow-up, survival rate of 95% was observed, and 4.9% mortality. Complications were esophagic stenosis 3.2%, recurrence of varicose veins in 6.5%, recurrence bleeding 4.09%, encephalopaty was not observed. Sugiura modified operation and sclerotherapy for management of HPH is safe as an alternative to decrease episodes of bleeding and eradication of esophagus gastric varicose veins as a cause.


REFERENCES

  1. Orozco H, Juárez G, Uribe M, et al. Sugiura procedure outside Japan. The Mexican experience. Am J Surg 1986;152:539.

  2. Orozco H, Guevara L Urtibe M, et al. Survival and quality of life after selective portosystemic shunts. Am J Surg 1981;141:183-186.

  3. Martínez C, Montes de Oca A, et al Tratamiento quirúrgico de la hipertensión portal hemorrágica, experiencia en un hospital de tercer nivel. México: Tesis IMSS CNMV ARC;1997.

  4. Orozco H, Mercado MA, et al. A comparative study of the elective treatment of varicela hemorrhage UIT B-blockers, transendoscopic sclerotherapy, and surgery. A prospective, controlled, and randomized trial during 10 years. Ann Surg 2000;2(2):216-219.

  5. Grace ND. The side–to-side portocaval shunt revisited. N Engl J Med 1994;330: 208-209.

  6. Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 1997;92(7):1081-1091.

  7. Wexler MJ, Stein BJ. Operaciones derivativas de várices sangrantes, Clin Q North Am 1990;2:445-446.

  8. Orozco H, Mercado MA, Takahashi T, et al. Elective treatment of leading varices with the Sugiura operation over 10 years. Am J Surg 1992;163:585-589.

  9. Swartz SI, Shires GT, Fisher JE, Spencer FC, et al. Principios de cirugía 7th ed. Vol. 2. México: McGraw-Hill Interamericana;2000.

  10. Cameron JL, Harrington DP, Maddrey WC. The mesocaval C shunt. Surg Gynecol Obstet 1980;150:401.

  11. Grozman RJ. Path physiology of cirrhotic portal hypertension. In: Boyer JL, Bianchi L, editors. Liver cirrhosis Lancaster, UK: Falk Foundation MPT Press;1987.

  12. Donovan AJ, Convey PC. Early history of the portacaval shunt in humans. Surg Gynecol Obstet 1978;147:423-430.

  13. Henderson JM. The distal splenorrenal shunt. Surg Clin North Am 1990;70:405-423.

  14. Besson, et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995;333:355-360.

  15. Warren WD, Zeppa R, Foman JS. Selective transplenic decompression of gastro-esophageal varices by distal splenorrenal shunts. Ann Surg 1967;166:437.

  16. Sarfeh IJ, Rypins EB. Small-diameter portocaval H-graft for variceal hemorrhage. Surg Clin North Am 1990;70:395-404.

  17. Sugiura M, FutagSawa S. Esophageal transection with paraesophagogastric devascularization (the Sugiura procedure) in the treatment of esophageal varices. World J Surg 1984;8(5):673.

  18. Hector Ferrol. Manejo de la hipertensión porto hemorrágica, nueva alternativa terapéutica. Rev Gastroenterol Mex 1994;59(3):209-210.

  19. Boylds H, Romanczyk T, Hartleb M, et al. Short-term effects of variceal sclerotherapy on portal hypertensive gastropathy. Endoscopy 1996;28:735-739.

  20. Sarin SK, Shahi HM, et al. The natural history of portal hypertensive gastropathy: influence of varicel eradication. Am J Gastroenterol 2000;95(10):2888-2893.




2020     |     www.medigraphic.com